Therapeutic Areas We Cover
Since 2015, Expert Clinical Trials has supported 45 clinical studies across nine therapeutic areas and every development phase, from Phase I through Phase IV, running sites in 10 countries. Oncology represents the core of our experience — 27 studies spanning breast, lung, colorectal, prostate, pancreatic, and renal cancers — complemented by depth in hematology, cardiology, and neurology, and hands-on work in nephrology, virology, bacteriology, anesthesiology, and medical devices.
Breast, lung, colorectal, prostate, pancreatic, and renal cancers, plus neuroendocrine tumors and melanoma, across Phases I through IV — run in Spain and internationally across Germany, the UK, the USA, France, Italy, Bulgaria, Hungary, and Poland.
Acute myeloid leukemia, Von Willebrand disease, lymphocytic leukemia, and relapsed or refractory multiple myeloma, Phases I through IV.
Chronic and acute heart failure and acute ischemic stroke, Phase III, across multiple sites in Spain.
Multiple sclerosis, Phase III, including a study followed for more than three years.
Endocrinology and subcutaneous transplantation devices, Phase I.
Renal impairment, COVID-19 infection, bacterial infections, and post-herpetic neuralgia, Phases I through IV, run in Spain and Portugal.
Want to know how we support trials across these areas? Explore our clinical operations consulting services, or contact us to discuss your study.